Opdivo (nivolumab)

pCPA File Number: 21043

Negotiation Status:

Concluded with an LOI

Indication(s):

Classic Hodgkin's Lymphoma

Sponsor/Manufacturer:

Bristol Myers Squibb Canada Inc.

CDA-AMC Project Number:

PC0120-000

pCPA Engagement Letter Issued:

2018-10-09

Negotiation Process Concluded:

2019-10-04